# 32 No Visible Disease: How Dale Atkinson Refused to Accept a Terminal Cancer Diagnosis
In one of the most extraordinary conversations to appear on the Integrative Medicine Matters podcast, Dr Elizabeth Thompson speaks with Dale Atkinson, a former financial crime investigator who was diagnosed with stage four oesophageal cancer in October 2024 and given less than twelve months to live.
The diagnosis arrived in the middle of an already devastating period: his partner had just undergone surgery for lung cancer, and his mother died within weeks of his own diagnosis. Rather than accepting a purely palliative path, Dale applied the same forensic, evidence-based thinking he had used for nearly two decades investigating financial crime to researching and designing his own integrative oncology protocol.
That protocol combined conventional immunotherapy and chemotherapy with mistletoe therapy, high-dose vitamin C, hyperbaric oxygen, infrared saunas, red light therapy, off-label medications, targeted supplementation and a rigorous anti-inflammatory nutrition plan, all mapped against next generation sequencing of his specific tumour genetics.
By July 2025 he had no visible signs of disease. In this conversation he shares exactly how he got there, what he learned about self-advocacy inside a resistant system, and why he has since co-founded the charity Beyond the Standard to push for systemic change in how Integrative Oncology approaches are recorded, researched and taken seriously.
KEY TOPICS DISCUSSED:
- Dale was diagnosed with inoperable, incurable stage four oesophageal cancer in October 2024 and given a prognosis of less than twelve months, yet by July 2025 scans showed no visible signs of disease.
- His background spending nearly two decades investigating financial crime gave him the research skills, evidence-based discipline and psychological resilience to interrogate his diagnosis and push back against the system.
- Next generation sequencing of his tumour genetics became the foundation of his protocol, identifying which chemotherapy agents, off-label medications and supplements were most likely to be effective for his specific cancer pathways.
- His full protocol at its peak included mistletoe therapy, high-dose vitamin C, hyperbaric oxygen, infrared saunas, red light therapy, 160 to 180 pills daily and monthly blood testing, requiring around six hours of treatment every day.
- When he eased off the protocol after achieving no visible disease, the cancer began to return; returning to the full protocol brought him back to no visible signs of disease, underlining how demanding long-term maintenance of an integrative protocol can be.
- Self-advocacy, the willingness to ask difficult questions, push back on clinical decisions and refuse to be pressured by fear or time pressure, was in Dale’s view one of the most significant factors in his survival.
- His NHS oncologist consistently discouraged his integrative approach, at one point advising him to eat a bar of chocolate and a pot of ice cream daily, illustrating how far mainstream nutritional guidance in oncology can lag behind the evidence.
- Around 76% of cancer patients use some form of complementary or alternative approach alongside standard of care, yet the NHS does not systematically record this, making it impossible to build the evidence base that would allow integrative oncology to be properly evaluated.
- Dale and Jane McLelland founded Beyond the Standard to push for systemic change, including proper recording of what patients are doing outside the system and greater openness to adjunct therapies within it.
- For anyone facing a serious diagnosis, Dale’s advice is simple: ask questions, become the slightly difficult patient, and do not let politeness get in the way of your survival.
About our guest:
Dale Atkinson spent nearly two decades working in financial crime prevention, regulatory compliance and governance for organisations including HSBC, Deutsche Bank, Wellington Management and Schroders.
In October 2024, he was diagnosed with stage IV oesophageal cancer and told his treatment would be palliative, following the death of his mother and his partner’s own cancer diagnosis within the space of a few weeks.
Drawing on the analytical skills that shaped his career, Dale researched and advocated for his own integrative care plan, combining conventional treatment with evidence-informed lifestyle, complementary and repurposed interventions. In 2026, scans showed no visible signs of disease.
Dale is now co-founder of Clear Signal Partners, a consultancy focused on trust, performance and hidden organisational risk, and owner of Peak Health & Fitness. He is also a founding trustee and director of the Pure Serenity Foundation and co-founder of the cancer charity Beyond the Standard.
He is developing a portfolio non-executive career across healthcare and financial services governance and writing Killing Dave – named after the tumour his eldest son named “Dave”.
If you’re interested in learning more about Integrative Medicine, you can:
👉 Sign up for our free newsletter Integrative Medicine Matters
👉 Sign up for our NCIM Membership, just £4.99 per month
👉 Sign up for our free Introduction to Integrative Medicine course
👉 Explore our 10 CPD Point Discovery Course in Integrative Medicine
👉 Find out more about our master’s Level 7 Diploma, including single modules you can enrol in today!
NCIM also offers an Integrative Medicine Clinic, where our expert team of Integrative Medicine Doctors and Integrative Clinical Team work collaboratively to support your health and wellbeing. Learn more and book an appointment.
We would love to get your feedback on the topics and conversations we feature. Follow and connect with us on social media – Instagram, Facebook, and LinkedIn – and let us know your thoughts.
Don’t forget to subscribe and share if you enjoyed this episode!
Disclaimer: This podcast is for educational purposes only and is not intended as medical advice. Always seek the guidance of a qualified healthcare professional before making any changes to your health or treatment plan.